Clinical Trial: The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: The Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty; A Single, Open,

Brief Summary: The purpose of this Clinical Trial was to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide acetate 3.75mg) in patients with precocious puberty.

Detailed Summary:
Sponsor: Daewoong Pharmaceutical Co. LTD.

Current Primary Outcome: At 24 weeks, percentage of subjects with suppression of peak-stimulated Luteinizing Hormone (LH) concentrations [ Time Frame: At 24 weeks ]

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Daewoong Pharmaceutical Co. LTD.

Dates:
Date Received: July 3, 2012
Date Started: July 2011
Date Completion:
Last Updated: August 1, 2014
Last Verified: August 2014